BMC Cardiovascular Disorders | |
Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry | |
Research Article | |
Hans-Henrik Tilsted1  Evald Høj Christiansen2  Jens Flensted Lassen2  Michael Maeng2  Leif Thuesen2  Anne Kaltoft2  Per Thayssen3  Lisette Okkels Jensen3  Morten Madsen4  Henrik Toft Sørensen5  | |
[1] Department of Cardiology, Aarhus University Hospital, Aalborg Hospital, Aalborg, Denmark;Department of Cardiology, Aarhus University Hospital, Skejby, Brendstrupgaardsvej 100, 8200, Aarhus N, Denmark;Department of Cardiology, Odense University Hospital, Odense, Denmark;Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark;Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark;Department of Epidemiology, Boston University, Boston, MA, USA; | |
关键词: Zotarolimus; Sirolimus; Stent; Mortality; Stent thrombosis; Diabetes mellitus; | |
DOI : 10.1186/1471-2261-12-84 | |
received in 2012-01-22, accepted in 2012-09-20, 发布年份 2012 | |
来源: Springer | |
【 摘 要 】
BackgroundWe evaluated the effectiveness and safety of a zotarolimus-eluting (ZES) versus a sirolimus-eluting (SES) coronary stent in a large cohort of patients treated with one of these stents in Western Denmark.MethodsA total of 6,122 patients treated with ZES (n=2,282) or SES (n=3,840) were followed for up to 27 months. We ascertained clinical outcomes based on national medical databases.ResultsIncidence of target lesion revascularization (no. per 100 person-years) was 5.3 in the ZES group compared to 1.9 in the SES group (adjusted hazard ratio (HR)=2.19, 95% confidence intervals (CI): 1.39-3.47; p=0.001). All-cause mortality was also higher in the ZES group (ZES: 6.3; SES: 3.3; adjusted HR=1.34, 95% CI: 1.05-1.72; p=0.02), while stent thrombosis (ZES: 1.2; SES: 0.5; adjusted HR=1.98, 95% CI: 0.75-5.23; p=0.14) did not differ significantly.ConclusionsIn agreement with previously published randomised data, this observational study indicated that the ZES was associated with an increased risk of death and TLR in a large cohort of consecutive patients.
【 授权许可】
CC BY
© Maeng et al.; licensee BioMed Central Ltd. 2012
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202311103610529ZK.pdf | 557KB | download |
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
- [29]
- [30]
- [31]
- [32]
- [33]
- [34]
- [35]
- [36]
- [37]
- [38]